Potassium canrenoate

From Wikipedia, the free encyclopedia
  (Redirected from Canrenoate potassium)
Jump to: navigation, search
Potassium canrenoate
Potassium canrenoate.svg
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Intravenous
ATC code C03DA02 (WHO)
Pharmacokinetic data
Metabolism Hepatic
Excretion Renal and fecal
Identifiers
Synonyms SC-14266
CAS Number 2181-04-6 N
PubChem (CID) 23671691
DrugBank DB09015 N
ChemSpider 570975 YesY
UNII M671F9NLEA N
ChEMBL CHEMBL1371200 N
ECHA InfoCard 100.016.868
Chemical and physical data
Formula C22H29KO4
Molar mass 396.5616 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Potassium canrenoate (INN, JAN) or canrenoate potassium (USAN) (brand names Venactone, Soldactone), also known as aldadiene kalium,[1] the potassium salt of canrenoic acid, is an aldosterone antagonist of the spirolactone group.[2] Like spironolactone, it is a prodrug, which is metabolized to canrenone in the body. Potassium canrenoate is not licensed in the UK, but may sometimes be prescribed off-licence to treat oedema. It is given intravenously.

See also[edit]

References[edit]

  1. ^ Hans Selye (17 April 2013). Hormones and Resistance: Part 1 and. Springer Science & Business Media. pp. 186–. ISBN 978-3-642-65192-2. 
  2. ^ R.A. Hill; H.L.J. Makin; D.N. Kirk; G.M. Murphy (23 May 1991). Dictionary of Steroids. CRC Press. pp. 656–. ISBN 978-0-412-27060-4.